21
Participants
Start Date
April 30, 2003
Primary Completion Date
April 30, 2008
ipilimumab
Given IV
therapeutic allogeneic lymphocytes
Given IV
Blood and Marrow Transplant Group of Georgia, Atlanta
Northside Hospital, Atlanta
Scripps Clinic - La Jolla, La Jolla
University of California San Diego, La Jolla
Dana-Farber Harvard Cancer Center, Boston
National Cancer Institute (NCI)
NIH